MAY 28, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Carbidopa AND Levodopa (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval of labeling changes for an established combination product; does not report clinical trial outcomes or comparative efficacy.
Reported
Approval status date2026-05-28
ANDA number077120